Ads
related to: pfizer stock price projection 2030superstockscreener.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Pfizer has set its biggest goals for 2030, but the growth to get there should happen in the months and years to come. As these revenue gains and new product launches happen, the stock could advance.
Pfizer (NYSE: PFE) is an interesting healthcare company with excellent prospects for cash flow growth. Where to invest $1,000 right now? ... *Stock prices used were the afternoon prices of Dec. 31 ...
Pfizer (NYSE: PFE) stock has suffered in recent times as revenue from its coronavirus treatment and vaccine has declined significantly from early-pandemic highs. But the pharma giant's launch of ...
The drugmaker's stock price has taken a significant hit, tumbling over 30% in the past 36 months. ... billion in risk-adjusted revenue by 2030. ... on revenue projections will be crucial. Pfizer ...
Pfizer wants this to be a transformative acquisition, and it projects Seagen to contribute $10 billion in sales by 2030. It said following the deal, it now has eight or more potential blockbuster ...
The story of Pfizer's stock over the last few years is inseparable from the trajectory of its coronavirus vaccine, Comirnaty. ... it expects to be treating twice as many patients in 2030 as the 2. ...
Pfizer's stock price was hammered, but that didn't prevent the company from meeting and raising its dividend commitment. ... It could generate more than $2 billion in sales by 2030 as a treatment ...
With the total return of Pfizer's (NYSE: PFE) shares rising by just 1.9% this year so far, investors may be yearning for some kind of catalyst that will stimulate its stock price to rise at a ...
Ads
related to: pfizer stock price projection 2030superstockscreener.com has been visited by 10K+ users in the past month